![Journal cover image](https://secure.syndetics.com/index.aspx?isbn=/lc.gif&issn=1558-1977&client=dukeuniv)
Diagnosis and management of heparin-induced thrombocytopenia.
Publication
, Journal Article
Lee, GM; Arepally, GM
Published in: Hematol Oncol Clin North Am
June 2013
Heparin-induced thrombocytopenia (HIT) is a prothrombotic disorder caused by antibodies to platelet factor 4/heparin (PF4/H) complexes. It presents with declining platelet counts 5 to 14 days after heparin administration and results in a predisposition to arterial and venous thrombosis. Establishing the diagnosis of HIT can be extremely challenging. It is essential to conduct a thorough clinical evaluation in addition to laboratory testing to confirm the presence of PF4/H antibodies. Multiple clinical algorithms have been developed to aid the clinician in predicting the likelihood of HIT. Once HIT is recognized, an alternative anticoagulant should be initiated to prevent further complications.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Hematol Oncol Clin North Am
DOI
EISSN
1558-1977
Publication Date
June 2013
Volume
27
Issue
3
Start / End Page
541 / 563
Location
United States
Related Subject Headings
- Thrombocytopenia
- Oncology & Carcinogenesis
- Humans
- Heparin
- Algorithms
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Lee, G. M., & Arepally, G. M. (2013). Diagnosis and management of heparin-induced thrombocytopenia. Hematol Oncol Clin North Am, 27(3), 541–563. https://doi.org/10.1016/j.hoc.2013.02.001
Lee, Grace M., and Gowthami M. Arepally. “Diagnosis and management of heparin-induced thrombocytopenia.” Hematol Oncol Clin North Am 27, no. 3 (June 2013): 541–63. https://doi.org/10.1016/j.hoc.2013.02.001.
Lee GM, Arepally GM. Diagnosis and management of heparin-induced thrombocytopenia. Hematol Oncol Clin North Am. 2013 Jun;27(3):541–63.
Lee, Grace M., and Gowthami M. Arepally. “Diagnosis and management of heparin-induced thrombocytopenia.” Hematol Oncol Clin North Am, vol. 27, no. 3, June 2013, pp. 541–63. Pubmed, doi:10.1016/j.hoc.2013.02.001.
Lee GM, Arepally GM. Diagnosis and management of heparin-induced thrombocytopenia. Hematol Oncol Clin North Am. 2013 Jun;27(3):541–563.
![Journal cover image](https://secure.syndetics.com/index.aspx?isbn=/lc.gif&issn=1558-1977&client=dukeuniv)
Published In
Hematol Oncol Clin North Am
DOI
EISSN
1558-1977
Publication Date
June 2013
Volume
27
Issue
3
Start / End Page
541 / 563
Location
United States
Related Subject Headings
- Thrombocytopenia
- Oncology & Carcinogenesis
- Humans
- Heparin
- Algorithms
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology